Altered visual depth perception and drugs of ingredients of gabapentin (a real world drug study)
Summary:
Altered visual depth perception is found among people who take drugs with ingredients of gabapentin, especially for people who are female, 40-49 old , have been taking the drugs for 6 - 12 months. This phase IV clinical study is created by eHealthMe based on reports of 415,239 people who have side effects when taking drugs with ingredients of gabapentin from the FDA, and is updated regularly.
Drug(s) considered in the study (i.e. both brand name and generic drugs): Gabapentin, Gralise, Neurontin.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
415,239 people reported to have side effects when taking drugs with ingredients of gabapentin.
Among them, 69 people (0.02%) have Altered visual depth perception
What is Altered visual depth perception?
Altered visual depth perception is found to be associated with 170 drugs and 332 conditions by eHealthMe. Check the latest studies of Altered visual depth perception.
Number of reports submitted per year:
Time on drugs with ingredients of gabapentin when people have Altered visual depth perception *:
- < 1 month: 0.0 %
- 1 - 6 months: 0.0 %
- 6 - 12 months: 33.33 %
- 1 - 2 years: 33.33 %
- 2 - 5 years: 0.0 %
- 5 - 10 years: 33.33 %
- 10+ years: 0.0 %
Gender of people who have Altered visual depth perception when taking drugs with ingredients of gabapentin *:
- female: 80 %
- male: 20 %
Age of people who have Altered visual depth perception when taking drugs with ingredients of gabapentin *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 22.22 %
- 40-49: 44.44 %
- 50-59: 19.44 %
- 60+: 13.89 %
Conditions people have *:
You may use this to check any potential undetected conditions.
Other drugs people take *:
You may use this to check any potential interacting drugs.
Other side effects people have besides Altered visual depth perception *:
You may use this to check any potential undetected side effects.
* Approximation only. Some reports may have incomplete information.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Related publications that referenced our studies
- de Landaluce, L. O., Carbonell, P., Asensio, C., Escoda, N., López, P., & Laporte, J. R. , "Gabapentin and Pregabalin and Risk of Atrial Fibrillation in the Elderly: A Population-Based Cohort Study in an Electronic Prescription Database", Drug safety, 2018 Jan .
- Scarff JR, "The Potential for Somnambulism Associated with Gabapentin", The Internet Journal of Psychiatry, 2014 Jan .
- de Landaluce, L. O., Carbonell, P., Asensio, C., Escoda, N., López, P., & Laporte, J. R. , "Gabapentin and Pregabalin and Risk of Atrial Fibrillation in the Elderly: A Population-Based Cohort Study in an Electronic Prescription Database", Drug safety, 2018 Jan .
- Scarff JR, "The Potential for Somnambulism Associated with Gabapentin", The Internet Journal of Psychiatry, 2014 Jan .
Related studies
Drugs with ingredients of gabapentin, their effectiveness, alternatives and more:
How the study uses the data?
The study uses data from the FDA. It is based on gabapentin. All drugs that have the same active ingredients (e.g. brand name and generic drugs) are considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Cleocin and Revlimid drug interactions for men aged 60+ - now
- Dyspnea and drugs of ingredients of rose hip - now
- Hypersensitivity and drugs of ingredients of tesamorelin acetate - now
- Blood Immunoglobulin G Increased and drugs of ingredients of fentanyl citrate - 2 seconds ago
- Bronchitis Chronic and drugs of ingredients of chlorhexidine gluconate - 3 seconds ago
- Cytomel vs. Thyrogen, side effect and effectiveness comparison - 3 seconds ago
- Fall and drugs of ingredients of acetaminophen; aspirin; caffeine - 6 seconds ago
- The Flu and drugs of ingredients of fondaparinux sodium - 7 seconds ago
- Amlodipine,Valsartan And Hydrochlorothiazide vs. Hyzaar, side effect and effectiveness comparison - 8 seconds ago
- Diverticulitis and drugs of ingredients of ezetimibe; simvastatin - 8 seconds ago